Main Street Investment Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Main Street Investment Advisors LLC

  • $730 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
BUY
$548.35 - $738.84 $274,175 - $369,420
500 New
500 $296,000
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $234,327 - $305,862
-475 Closed
0 $0
Q1 2020

May 11, 2020
BUY
$336.18 - $494.43 $159,685 - $234,854
475 New
475 $232,000

Others Institutions Holding REGN

# of Institutions
1,500
Shares Held
83M
Call Options Held
1.22M
Put Options Held
1.5M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Main Street Investment Advisors LLC Portfolio

Follow Main Street Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email